go to contents go to 1depth menu
Aiming to be a global drug maker

RESEARCH AREA

We will introduce about the various research areas of CJ HealthCare.

Based technology
  • Genetic
  • Culture
  • Purification
  • Scale-up
Specific area
Specific technology
development of new drug
+ Differentiating technology
CJ-40001 DTRAP, HUBA CJ-40010, 40011 CJ-40012 TANKIO
Biologicals Renal
Anemia
Rheumatoid
Arthritis
Prevention of
Hand, Foot &
Mouth Disease,
Smallpox
Senior macular
degeneration
Immuno
Oncology

CJ HealthCare Corp. is developing various biologicals based on its R&D capabilities and commercialization of interferon alpha and beta, GCSF, EPO, and others. It is currently studying second-generation protein drugs, antibodies, and distinguished vaccines based on such development experience.